119 related articles for article (PubMed ID: 20063525)
41. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer.
Grann A; Minsky BD; Cohen AM; Saltz L; Guillem JG; Paty PB; Kelsen DP; Kemeny N; Ilson D; Bass-Loeb J
Dis Colon Rectum; 1997 May; 40(5):515-22. PubMed ID: 9152176
[TBL] [Abstract][Full Text] [Related]
42. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer.
Das P; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Wolff RA; Eng C; Krishnan S; Janjan NA; Crane CH
Cancer; 2007 May; 109(9):1750-5. PubMed ID: 17387743
[TBL] [Abstract][Full Text] [Related]
43. Neoadjuvant accelerated concomitant boost radiotherapy and multidrug chemotherapy in locally advanced rectal cancer: a dose-escalation study.
Caravatta L; Picardi V; Tambaro R; Padula GD; Macchia G; Deodato F; Massaccesi M; Pacelli F; Berardi S; Ridolfini MP; Di Filippo L; Fabrizio G; Ingrosso M; Cellini N; Valentini V; Morganti AG
Am J Clin Oncol; 2012 Oct; 35(5):424-31. PubMed ID: 21555930
[TBL] [Abstract][Full Text] [Related]
44. Preoperative long-course chemoradiation for localized rectal cancer: A retrospective comparison of response and outcome between 5-fluorouracil/leucovorin versus capecitabine.
Kunheri B; Gurram B; Madhavan R; Makuny D
Indian J Cancer; 2016; 53(4):518-523. PubMed ID: 28485342
[TBL] [Abstract][Full Text] [Related]
45. Outcomes of Preoperative Chemoradiotherapy and Combined Chemotherapy with Radiotherapy Without Surgery for Locally Advanced Rectal Cancer.
Supaadirek C; Pesee M; Thamronganantasakul K; Thalangsri P; Krusun S; Supakalin N
Asian Pac J Cancer Prev; 2016; 17(7):3511-4. PubMed ID: 27510001
[TBL] [Abstract][Full Text] [Related]
46. The impact of 5-fluorouracil and intraoperative electron beam radiation therapy on the outcome of patients with locally advanced primary rectal and rectosigmoid cancer.
Nakfoor BM; Willett CG; Shellito PC; Kaufman DS; Daly WJ
Ann Surg; 1998 Aug; 228(2):194-200. PubMed ID: 9712564
[TBL] [Abstract][Full Text] [Related]
47. Tumour regression grading in the evaluation of tumour response after different preoperative radiotherapy treatments for rectal carcinoma.
Vironen J; Juhola M; Kairaluoma M; Jantunen I; Kellokumpu I
Int J Colorectal Dis; 2005 Sep; 20(5):440-5. PubMed ID: 15856263
[TBL] [Abstract][Full Text] [Related]
48. Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy.
Marsh RD; Chu NM; Vauthey JN; Mendenhall WM; Lauwers GY; Bewsher C; Copeland EM
Cancer; 1996 Jul; 78(2):217-25. PubMed ID: 8673995
[TBL] [Abstract][Full Text] [Related]
49. Effect of preoperative concurrent chemoradiotherapy in locally advanced low rectal cancer after radical resection surgery.
Lam CW; Chen WT; Liu MT; Chang CS; Huang TM; Hsu GH; Chen HC; Hsiao KH; Chiu CM; You JJ
Int Surg; 2005; 90(1):53-9. PubMed ID: 15912902
[TBL] [Abstract][Full Text] [Related]
50. Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: Phase I and II studies.
Gambacorta MA; Valentini V; Coco C; Morganti AG; Smaniotto D; Miccichè F; Mantini G; Barbaro B; Garcia-Vargas JE; Magistrelli P; Picciocchi A; Cellini N
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):139-48. PubMed ID: 15337549
[TBL] [Abstract][Full Text] [Related]
51. Investigation of the comparative toxicity of 5-FU bolus versus 5-FU continuous infusion circadian chemotherapy with concurrent radiation therapy in locally advanced rectal cancer.
Thrall MM; Wood P; King V; Rivera W; Hrushesky W
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):873-81. PubMed ID: 10705008
[TBL] [Abstract][Full Text] [Related]
52. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
[TBL] [Abstract][Full Text] [Related]
53. A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon.
Czito BG; Hong TJ; Cohen DP; Tyler DS; Lee CG; Anscher MS; Ludwig KA; Seigler HF; Mantyh C; Morse MA; Lockhart AC; Petros WP; Honeycutt W; Spector NL; Ertel PJ; Mangum SG; Hurwitz HI
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):779-85. PubMed ID: 14967434
[TBL] [Abstract][Full Text] [Related]
54. Thymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with rectal adenocarcinoma.
Tan BR; Thomas F; Myerson RJ; Zehnbauer B; Trinkaus K; Malyapa RS; Mutch MG; Abbey EE; Alyasiry A; Fleshman JW; McLeod HL
J Clin Oncol; 2011 Mar; 29(7):875-83. PubMed ID: 21205745
[TBL] [Abstract][Full Text] [Related]
55. Intravenous 5-fluorouracil versus oral doxifluridine as preoperative concurrent chemoradiation for locally advanced rectal cancer: prospective randomized trials.
Kim NK; Min JS; Park JK; Yun SH; Sung JS; Jung HC; Roh JK
Jpn J Clin Oncol; 2001 Jan; 31(1):25-9. PubMed ID: 11256837
[TBL] [Abstract][Full Text] [Related]
56. Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092).
Valentini V; De Paoli A; Gambacorta MA; Mantini G; Ratto C; Vecchio FM; Barbaro B; Innocente R; Rossi C; Boz G; Barba MC; Frattegiani A; Lupattelli M; Doglietto GB
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):644-9. PubMed ID: 18395356
[TBL] [Abstract][Full Text] [Related]
57. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
58. Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3-T4 unresectable rectal cancer: a phase II IATTGI study.
Carraro S; Roca EL; Cartelli C; Rafailovici L; Castillo Odena S; Wasserman E; Gualdrini U; Huertas E; Barugel M; Ballarino G; Rodriguez MC; Masciangioli G
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):397-402. PubMed ID: 12243813
[TBL] [Abstract][Full Text] [Related]
59. Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma.
Crane CH; Skibber JM; Feig BW; Vauthey JN; Thames HD; Curley SA; Rodriguez-Bigas MA; Wolff RA; Ellis LM; Delclos ME; Lin EH; Janjan NA
Cancer; 2003 Jan; 97(2):517-24. PubMed ID: 12518377
[TBL] [Abstract][Full Text] [Related]
60. Preoperative chemotherapy and radiotherapy for locally advanced rectal cancer.
Chao M; Gibbs P; Tjandra J; Cullinan M; McLaughlin S; Faragher I; Skinner I; Jones I
ANZ J Surg; 2005 May; 75(5):286-91. PubMed ID: 15932438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
